Clinical Trial Update: Assessment of Chemotherapy-induced Peripheral Neurotoxicity Using a Point-of-care Nerve Conduction Study Device

View source ↗

Summary

A completed clinical trial evaluated a point-of-care nerve conduction device to assess chemotherapy-induced peripheral neurotoxicity in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Oulu University Hospital | Conditions: Cancer | Status: COMPLETED